Oleoresin Market Size to Reach $2.54 Billion by 2031 as Demand for Clean-Label Extracts and Advanced Botanical Processing Gains Momentum – Mordor Intelligence

Oleoresin Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the oleoresin market, offering a comprehensive analysis of market trends, growth drivers, competitive dynamics,

Read More

Hyperphosphatemia Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Ardelyx, Sanofi, Takeda Pharma, Unicycive Therapeutics, Taisho Pharma

(Albany, New York) – September 22, 2026: The Key Hyperphosphatemia Companies in the market include – Ardelyx, Sanofi, Takeda Pharma, Unicycive Therapeutics, Taisho Pharma, Alebund Pharmaceuticals, FRESENIUS MEDICAL CARE RENAL

Read More

Multiple Sclerosis Pipeline 2026: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Biogen, Immune Response BioPharma, Celgene, Novartis, Sanofi, Actelion, Baye

(Albany, New York) – September 22, 2026: (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Multiple Sclerosis pipeline constitutes 75+ key companies continuously working towards developing 80+ Multiple

Read More

Fabry Disease Market Growth Outlook 2036: Epidemiology, Pipeline Therapies, and Revenue Forecast – DelveInsight | Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, AVROBIO, 4D Molecular

(Albany, New York) – September 22, 2026: The Key Fabry Disease Companies in the market include – Chiesi and Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Protalix Biotherapeutics, AVROBIO, Sanofi Genzyme,

Read More

Chronic Insomnia Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 – DelveInsight | IDORSIA, EISAI, Janssen R&D, Takeda

(Albany, New York) – September 22, 2026: The Key Chronic Insomnia Companies in the market include – IDORSIA, EISAI, Janssen Research & Development, Takeda, and others.   The Chronic Insomnia

Read More

Diabetic Peripheral Neuropathy Pipeline 2026: MOA and ROA Insights, Clinical Trials Status, and Key Companies Involved by DelveInsight | Helixmith, Lexicon Pharma, Glenmark Pharma, Praetego

(Albany, New York) – September 22, 2026: (Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diabetic Peripheral Neuropathy pipeline constitutes 15+ key companies continuously working towards developing 20+

Read More

Diffuse Large B-Cell Lymphoma Clinical Trials Drugs Development Pipeline Expands with Contributions from 70+ Key Companies | DelveInsight

The Diffuse Large B-Cell Lymphoma Clinical Trials analysis report delivers important insights into ongoing research of 70+ pipeline Diffuse Large B-Cell Lymphoma Drugs, clinical strategies, upcoming therapeutics, and commercial analysis.

Read More

Netherton Syndrome Clinical Trial Drug Development Pipeline Expands with Contributions from 4+ Key Companies | DelveInsight

The Netherton Syndrome Clinical Trials analysis report delivers important insights into ongoing research of 4+ pipeline Netherton Syndrome Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 22,

Read More

MRSA Infections Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 25+ Leading Players Wheeling the Therapeutics Landscape

The MRSA Infections Clinical Trials analysis report delivers important insights into ongoing research of 25+ pipeline MRSA Infections Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US), September 22,

Read More

Bladder Cancer Clinical Trial Pipeline: Emerging Therapies and Key Developments Shaping the Treatment Landscape | DelveInsight

The Bladder Cancer clinical trial analysis report delivers important insights into ongoing research on 80+ pipeline Bladder Cancer Drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US) September 22,

Read More

Chronic Kidney Disease Pipeline Insights Gains Momentum: 75+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

The Chronic Kidney Disease clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline Chronic Kidney Disease drugs, clinical strategies, upcoming therapeutics, and commercial analysis. (Albany, US)

Read More

Pelizaeus-Merzbacher Disease Market Poised for Growth as Awareness Increases and Targeted Interventions Advance Through the Pipeline

Key Pelizaeus-Merzbacher Disease companies such as Ionis Pharmaceuticals Inc., StemCells Inc., Aldagen, and others. (Albany, New York) – 22nd Sep 2026 – DelveInsight’s “Pelizaeus-Merzbacher Disease Treatment Market Insights, Epidemiology, and Market

Read More

Hashimoto’s Thyroiditis Market Size, Share, Growth, Epidemiology and Forecast to 2036

Hashimoto’s Thyroiditis – Market Insights, Epidemiology, and Market Forecast – 2036, provides a comprehensive assessment of the Hashimoto’s Thyroiditis market across the United States, EU4 (Germany, France, Italy, and Spain),

Read More

Ocular Motility Disturbance Market Set for Growth as Diagnostic Advances and Expanding Pipeline Reshape Treatment Landscape

Key Ocular Motility Disturbance companies such as Abbott Laboratories, Alcon Vision LLC, AbbVie Inc. (via Allergan), Novartis AG, Roche Holding AG, Johnson & Johnson, Carl Zeiss Meditec AG, Essilor International

Read More

Mucopolysaccharidosis Type I Market Size, Share, Growth, Epidemiology and Forecast to 2036

Mucopolysaccharidosis Type I (MPS I) Market Insights, Epidemiology, and Market Forecast – 2036, provides a comprehensive assessment of the MPS I market across the United States, EU4 (Germany, France, Italy,

Read More

Glioblastoma Market Set to Expand from USD 799 Million as New Therapies and a Robust Pipeline Advance Through 2034Glioblastoma (GBM) Market

Glioblastoma is the most frequently occurring type of primary tumor of the central nervous system, mostly in adults, and is often located in the cerebrum, which controls advanced processes such

Read More

Secondary Hyperparathyroidism (SHPT) Market Set for Consistent Growth Through 2032 as Calcimimetic Pipeline Expands

Secondary hyperparathyroidism is a medical condition in which the parathyroid glands secrete excessive amounts of parathyroid hormone (PTH) in response to hypocalcemia, leading to hyperplasia of these glands, with chronic

Read More

ALK Inhibitors Market Size, Share, Growth, Epidemiology and Forecast to 2036

ALK Inhibitors – Target Population, Competitive Landscape, and Market Forecast – 2036, provides a comprehensive assessment of the ALK Inhibitors market across the United States, EU4, the United Kingdom, and

Read More

The Global Optical Coherence Tomography (OCT) Devices Market Size is projected to grow at a CAGR of 8.57% during the forecast period from 2024 to 2030 | DelveInsight

The Optical Coherence Tomography (OCT) Devices market is estimated at USD 1.22 billion in 2023 and is projected to reach USD 2.00 billion by 2030. Growth is anchored in the

Read More

Commercial Office Furniture Is Moving from Individual Product Purchasing to Project-Based Solutions

Corporate Workspaces Are Evolving from “Product Combinations” into “Space Systems” Los Angeles, California – September 22, 2026 – Modern offices often include workstations, private offices, meeting & collaboration spaces, reception,

Read More